1120647

Elite Laboratories Inc. — FEI 3002644678

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
March 13, 2020
Fiscal Year
2020
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Northvale, NJ (United States)

Additional Details

Risk Evaluation and Mitigation Strategies (REMS)

Citations

IDCFRDescription
21353FDCA 505-1(e)(3)Failure to comply with REMS Communication Plan